Global Patent Index - EP 2863907 A1

EP 2863907 A1 20150429 - PHARMACEUTICAL COMPOSITION HAVING SYNERGISTIC ACTION OF DIRECT CATALASE INHIBITORS AND MODULATORS OF NO METABOLISM OR OF EXTRACELLULAR SUPEROXIDE ANION PRODUCTION WHICH LEAD TO CATALASE DESTRUCTION

Title (en)

PHARMACEUTICAL COMPOSITION HAVING SYNERGISTIC ACTION OF DIRECT CATALASE INHIBITORS AND MODULATORS OF NO METABOLISM OR OF EXTRACELLULAR SUPEROXIDE ANION PRODUCTION WHICH LEAD TO CATALASE DESTRUCTION

Title (de)

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT SYNERGISTISCHER WIRKUNG VON DIREKTEN KATALASEINHIBITOREN UND ZUR KATALASEZERSTÖRUNG FÜHRENDEN MODULATOREN DES NO-STOFFWECHSELS ODER DER EXTRAZELLULÄREN SUPEROXIDANIONENPRODUKTION

Title (fr)

COMPOSITION PHARMACEUTIQUE À L'ORIGINE D'UNE ACTION SYNERGIQUE D'INHIBITEURS DE CATALASE DIRECTS ET DE MODULATEURS DU MÉTABOLISME DE NO OU DE LA PRODUCTION D'ANIONS DE SUPEROXYDE EXTRACELLULAIRES, QUI CONDUISENT À LA DESTRUCTION DE LA CATALASE

Publication

EP 2863907 A1 20150429 (DE)

Application

EP 13729758 A 20130620

Priority

  • EP 12173548 A 20120626
  • EP 2013062822 W 20130620
  • EP 13729758 A 20130620

Abstract (en)

[origin: EP2679225A1] Composition comprises at least one active ingredient, which brings a singlet oxygen-independent direct catalase inactivation, where the composition further comprises at least one active ingredient, which leads to inactivation of catalase as a result of modulation of the nitrogen oxide or superoxide anion metabolism of the cells and subsequent singlet oxygen formation. ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given.

IPC 8 full level

A61K 31/35 (2006.01); A61K 31/055 (2006.01); A61K 31/19 (2006.01); A61K 31/198 (2006.01); A61K 31/337 (2006.01); A61K 31/352 (2006.01); A61K 31/375 (2006.01); A61K 31/454 (2006.01); A61K 31/55 (2006.01); A61K 39/395 (2006.01); A61P 9/00 (2006.01); A61P 9/04 (2006.01); A61P 9/12 (2006.01); A61P 35/00 (2006.01)

CPC (source: EP US)

A61K 31/05 (2013.01 - EP US); A61K 31/10 (2013.01 - EP US); A61K 31/105 (2013.01 - EP US); A61K 31/198 (2013.01 - EP US); A61K 31/26 (2013.01 - EP US); A61K 31/337 (2013.01 - EP US); A61K 31/352 (2013.01 - EP US); A61K 31/366 (2013.01 - EP US); A61K 31/375 (2013.01 - EP US); A61K 31/4164 (2013.01 - EP US); A61K 31/4196 (2013.01 - EP US); A61K 31/426 (2013.01 - EP US); A61K 31/427 (2013.01 - EP US); A61K 31/496 (2013.01 - EP US); A61K 31/519 (2013.01 - EP US); A61K 31/60 (2013.01 - EP US); A61K 31/69 (2013.01 - EP US); A61P 9/04 (2017.12 - EP US); A61P 9/12 (2017.12 - EP US); C07K 16/40 (2013.01 - EP US); C07K 2317/24 (2013.01 - US); C07K 2317/76 (2013.01 - EP US)

Citation (search report)

See references of WO 2014001183A1

Citation (examination)

  • US 6509370 B1 20030121 - JOSHI-HANGAL RAJASHREE [US], et al
  • WO 2011050735 A1 20110505 - INST MATERIA MEDICA CAMS [CN], et al
  • WO 2012018597 A2 20120209 - CHEMOTHERAPEUTICS LLC [US], et al
  • CN 101130724 A 20080227 - HUANRAN ZHAO [CN]
  • US 2010172941 A1 20100708 - VAJDY MICHAEL [US], et al
  • GB 2346325 A 20000809 - WASSEN INT LTD [GB]
  • EP 2135512 A1 20091223 - MUIN ALI DR [AT]
  • GB 2208598 A 19890412 - CIBA GEIGY AG [CH]
  • CN 1097601 A 19950125 - LI LEXUAN [CN]
  • CN 101889973 A 20101124 - UNIV NORTHEAST AGRICULTURAL
  • ES 2349966 A1 20110113 - UMBERT MILLET IGNACIO [ES]
  • PITARI G ET AL: "Biochemical and ultrastructural alterations in rat after hyperoxic treatment: effect of taurine and hypotaurine", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, SPRINGER, US, vol. 483, 1 January 2000 (2000-01-01), pages 149 - 156, XP009189517, ISSN: 0065-2598
  • KIRYU C ET AL: "Physiological production of singlet molecular oxygen in the myeloperoxidase-H2O2-chloride system", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 443, no. 2, 29 January 1999 (1999-01-29), pages 154 - 158, XP004259109, ISSN: 0014-5793, DOI: 10.1016/S0014-5793(98)01700-1
  • DATABASE BIOLOGICAL ABSTRACTS. - M [online] 15 February 1978 (1978-02-15), ROSEN H ET AL: "FORMATION OF SINGLET OXYGEN BY THE MYELOPEROXIDASE-MEDIATED ANTIMICROBIAL SYSTEM", XP002094447, retrieved from BIOLOGICAL Database accession no. 21608
  • PARK J H ET AL: "175 Synergetic and alleviatory effects by combinational therapy of ascorbic acid and paclitaxel on sarcoma 180 implanted BALB/c mice", EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 8, no. 5, 1 June 2010 (2010-06-01), pages 46, XP027105412, ISSN: 1359-6349, [retrieved on 20100601]
  • ORR ET AL: "The inhibition of catalase by ascorbic acid", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 23, no. 6, 21 June 1966 (1966-06-21), pages 854 - 860, XP024777717, ISSN: 0006-291X, [retrieved on 19660621], DOI: 10.1016/0006-291X(66)90566-3
  • DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1948, FOULKES E C ET AL: "The inhibition of catalase by ascorbic acid", Database accession no. EMB-0007219939 & FOULKES E C ET AL: "The inhibition of catalase by ascorbic acid", AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE 1948, vol. 26, no. 4, 1948, pages 307 - 313, ISSN: 0004-945X
  • DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1981, JONES D P: "INTRA CELLULAR INHIBITION OF CATALASE BY ALPHA METHYL DOPA", Database accession no. PREV198273050741 & JONES D P: "INTRA CELLULAR INHIBITION OF CATALASE BY ALPHA METHYL DOPA", RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, vol. 33, no. 2, 1981, pages 215 - 222, ISSN: 0034-5164
  • DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1 August 1995 (1995-08-01), CONRATH U ET AL: "Two inducers of plant defense responses, 2,6-dichloroisonicotinic acid and salicylic acid, inhibit catalase activity in tobacco", Database accession no. EMB-1995239220 & CONRATH U ET AL: "Two inducers of plant defense responses, 2,6-dichloroisonicotinic acid and salicylic acid, inhibit catalase activity in tobacco", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 19950801 US, vol. 92, no. 16, 1 August 1995 (1995-08-01), pages 7143 - 7147, ISSN: 0027-8424

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

EP 2679225 A1 20140101; EP 2863907 A1 20150429; US 2015335663 A1 20151126; US 9801832 B2 20171031; WO 2014001183 A1 20140103

DOCDB simple family (application)

EP 12173548 A 20120626; EP 13729758 A 20130620; EP 2013062822 W 20130620; US 201314410221 A 20130620